Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 24, 2003American Journal of Hematology

High‐dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

EREmmanuelle de RaucourtHôpital BeaujonCBChristophe BarbierBillerudKorsnäs (Sweden)PSP Sinda

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Raucourt et al. (2003) studied this question.

synapsesocial.com/papers/6a83ddfe5dc7077fe9c58bdehttps://doi.org/10.1002/ajh.10420
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients1993 · 69 citations
  2. 2Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune Diseases1999 · 430 citations
  3. 3High‐titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors2002 · 40 citations
  4. 4Inhibitory Anti–Factor V Antibodies Bind to the Factor V C2 Domain and Are Associated With Hemorrhagic Manifestations1998 · 85 citations
  5. 5Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure2002 · 200 citations